Kiyoshi Oizumi

Statistics

Publications

Citations

675

H-Index

Active since

1984

Affiliations

Daiichi-Sankyo (Japan)(Current)

Biomedical Research Laboratories (United States)

Daiichi Sankyo (Germany)

Ube (Japan)

University of Toronto

Kiyoshi Oizumi is an author at Daiichi-Sankyo (Japan) specializing in pharmacology, antihypertensive pharmacology, and cardiovascular pharmacotherapy.

Publications per year

1984–2013

Publications

Angiotensin-converting enzyme inhibitors. Perhydro-1,4-thiazepin-5-one derivatives

Hiroaki Yanagisawa, Sadao Ishihara, Akiko Ando et al. · Journal of Medicinal Chemistry · 1987 · 73 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8

Studies of Novel 1, 4-Dihydropyridine Ca Antagonist CS-905. I. Measurement of Partition Coefficient (logP) by High Performance Liquid Chromatography (HPLC)

Akira Takeyasu, Kiyoshi Oizumi, Takashi Kobayashi · YAKUGAKU ZASSHI · 1995 · 62 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

Antihypertensive effects of CS-905, a novel dihydropyridine Ca++ channel blocker.

Kiyoshi Oizumi, Hiroshi Nishino, Hiroyuki Koike et al. · The Japanese Journal of Pharmacology · 1989 · 61 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Atrial natriuretic factor selectively increases renal blood flow in conscious spontaneously hypertensive rats

Hiroyuki Koike, Toshio Sada, Masaaki Miyamoto et al. · European Journal of Pharmacology · 1984 · 58 citations

Medicine, Pharmacology, Physiology +13

Angiotensin-converting enzyme inhibitors. 2. Perhydroazepin-2-one derivatives

Hiroaki Yanagisawa, Sadao Ishihara, Akiko Ando et al. · Journal of Medicinal Chemistry · 1988 · 46 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

1–5 of 20